News Search Results
May 21, 2025, 07:00 ET Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509, Coinciding with Preclinical Data Presentations Further Validating Novel Kallikrein 5/7 Biology in Atopic Dermatitis
May 21, 2025 /PRNewswire/ -- Triveni Bio, Inc., a biotechnology company focused on developing innovative antibody treatments for inflammation and immunology (I&I) disorders, today announced the initiation
More news about: Triveni Bio
May 21, 2025, 02:32 ET Aquaporin Q1 2025 Trading Statement - maintains full-year financial guidance for 2025
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Company's Q1 2025 Trading Statement for the period January 1 to March 31, 2025. "In
More news about: Aquaporin A/S
May 21, 2025, 02:30 ET Aquaporin Q1 2025 Trading Statement - maintains full-year financial guidance for 2025
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Company's Q1 2025 Trading Statement for the period January 1 to March 31, 2025. "In
More news about: Aquaporin A/S
May 20, 2025, 14:40 ET Rubin and Rudman Partner Matthew Joyce Named to 2025 Lawdragon 500 Leading Tax Lawyers
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
May 20, 2025, 13:43 ET SGS Announces ISO 17025 Accreditation of Canadian Pharmaceutical Lab Now Offering Extractables and Leachables Testing
global network of contract analytical laboratories. As such, it is well positioned to deliver harmonized solutions to large pharmaceutical and biotechnology firms, while also being able to service smaller manufacturers with bundled or stand-alone testing services. The company also provides Phase I-IV
More news about: SGS
May 20, 2025, 09:00 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
May 20, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
May 20, 2025, 09:00 ET TurtleTree Secures FDA "No Questions" Letter for World's First Precision-Fermented Lactoferrin
https://sites.google.com/turtletree.com/media/home About TurtleTree TurtleTree is a global biotechnology company pioneering the use of precision fermentation to unlock the full potential of bioactive milk ingredients, starting with lactoferrin. By combining
More news about: TurtleTree
May 20, 2025, 09:00 ET On-Point Defense Technologies and Hughes Tool Company Join Forces to Deliver Next-Generation Energy Platform for Leading U.S. Wireless Carriers
deliver results that are both practical and transformative. This alliance enhances Hughes' eMpower NeverFail Support Systems (NFSS) across biotechnology and pharmaceutical sectors, where energy-efficient refrigeration and power reliability are mission-critical. Hughes' eMpower™ platform is uniquely
More news about: Hughes Tool Company
May 20, 2025, 08:35 ET Precision Announces Promotion of Sofia Baig to President, Precision for Medicine and Appointment of Daisy DeWeese-Gatt, MPH, as President, Clinical Solutions, Precision for Medicine
President, Precision for Medicine, Ms. Baig oversees Translational Sciences and Clinical Solutions services provided to leading innovators in the biotechnology and pharmaceutical sectors. Precision integrates central and specialty lab services with global contract research organization (CRO) services to
More news about: Precision for Medicine
May 20, 2025, 08:00 ET Mariano A. Garcia-Blanco, co-founder of Autoimmunity BioSolutions, was elected to the National Academy of Sciences
HOUSTON, May 20, 2025 /PRNewswire/ -- Autoimmunity BioSolutions (ABS), a biotechnology company pioneering targeted, immuno-corrective therapy for a highly prevalent, genetically-defined subpopulation of patients that suffer from autoimmune
More news about: Autoimmunity BioSolutions
May 20, 2025, 08:00 ET IDT Biologika Accelerates Global Growth Through Strategic CDMO Partnership
engagement, the company is scheduled to attend BIO International Convention (BIO US), the world's largest biotechnology industry event, taking place in Boston from June 16 to 19. Meanwhile, following
More news about: SK bioscience
May 20, 2025, 06:54 ET Regenics AS completes second tranche of private placement to continue development of Collex®
Norway, May 20, 2025 /PRNewswire/ -- Regenics AS, a private Norwegian biotechnology company based in Oslo (the "Company"), today announced that it has closed the second tranche of a non-brokered
More news about: Regenics AS
May 20, 2025, 05:45 ET Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline
May 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
May 20, 2025, 05:00 ET Trailhead Biosystems Announces David Llewellyn, PhD, MBA, as Chief Executive Officer
Ohio, May 20, 2025 /PRNewswire/ -- Trailhead Biosystems Inc. (TrailBio.com), a biotechnology company pioneering the creation of iPSC-derived human cells at scale for drug discovery and cell therapy, is pleased to announce the appointment
More news about: Trailhead Biosystems Inc
May 20, 2025, 02:36 ET Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
May 20, 2025, 02:32 ET Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
May 20, 2025, 01:51 ET Skanska signs additional contract for biotechnology facility in Charlottesville, USA, for USD 66M, about SEK 690M
additional contract with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at Fontaine Research Park in Charlottesville, Virginia. The additional contract is worth USD
More news about: Skanska
May 19, 2025, 21:44 ET WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories
multiple indices, such as the Hang Seng Composite Index (HSCI), the Hang Seng Hong Kong Listed Biotechnology Index (HSHKBIO), the Hang Seng Healthcare Index (HSHCI), the Hang Seng Hong Kong US Biotechnology Index (HSUSB), and the FTSE All-Cap, etc. In the realm of capital market accolades, the company
More news about: WuXi XDC
May 19, 2025, 21:03 ET PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection
May 19, 2025 /PRNewswire/ -- PHASE Scientific International Limited ("PHASE Scientific"), a pioneering biotechnology company revolutionizing early disease detection through proprietary urine-based diagnostics, today announced the successful completion of a
More news about: PHASE Scientific
May 19, 2025, 17:31 ET Intra-tumoral Cancer Therapies Market to Show Tremendous Growth at a CAGR of 31.3% During the Study Period (2020-2034) | DelveInsight
Pharmaceuticals, Ascend Biopharmaceuticals, Replimune, Highlight Therapeutics, Cytovation ASA, Intensity Therapeutics, Ascendis Pharma, Treovir, Matica Biotechnology, QBiotics, NanOlogy, Lokon Pharma AB, EpicentRx, Medicenna Therapeutics, Philogen S.p.A., Candel Therapeutics, Lytix Biopharma, Verrica Pharmaceuticals,
More news about: DelveInsight Business Research, LLP
May 19, 2025, 16:05 ET REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
served as legal advisor to REGENXBIO and Morgan, Lewis & Bockius LLP advised HCRx. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
May 19, 2025, 15:06 ET Chemicals for Cosmetics & Toiletries to Reach $35.0 Billion by 2029: Global Market Trends
growth. Technological Innovations in Cosmetics and Toiletries: Advances such as AI for personalized skincare, AR for virtual try-ons, and biotechnology for lab-grown ingredients are transforming the industry. Sustainable practices, such as waterless products and refillable packaging, are also gaining
More news about: BCC Research LLC
May 19, 2025, 14:08 ET Regenics AS appoints Jostein Grip as new CEO
Norway, May 19, 2025 /PRNewswire/ -- Regenics AS, a private Norwegian biotechnology company based in Oslo, today announced that it has appointed Jostein Grip as the
More news about: Regenics AS
May 19, 2025, 13:04 ET Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANA
May 19, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm
May 19, 2025, 10:30 ET eCOA Solutions Market worth US$4.78 billion by 2030 with 16.1% CAGR | MarketsandMarkets™
for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market. This region is home to numerous pharmaceutical and biotechnology companies that utilize electronic Clinical Outcome Assessment (eCOA) solutions. These companies conduct extensive clinical trials, aiming for efficient
More news about: MarketsandMarkets